| Original language | English (US) |
|---|---|
| Pages (from-to) | S1-S8 |
| Journal | Clinical Gastroenterology and Hepatology |
| Volume | 20 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 2022 |
| Externally published | Yes |
Keywords
- Cognitive Dysfunction
- Encephalopathy
- Liver Disease
ASJC Scopus subject areas
- Hepatology
- Gastroenterology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Clinical Gastroenterology and Hepatology, Vol. 20, No. 8, 08.2022, p. S1-S8.
Research output: Contribution to journal › Review article › peer-review
}
TY - JOUR
T1 - Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy
AU - Louissaint, Jeremy
AU - Deutsch-Link, Sasha
AU - Tapper, Elliot B.
N1 - Funding Information: Jeremy Louissaint (Concept; Analysis; Data acquisition; Writing), Sasha Deutsch-Link (Concept; Analysis; Data acquisition; Writing), Elliot B. Tapper (Concept; Analysis; Data acquisition; Writing), This paper is part of a supplement supported by an independent educational grant from Salix Pharmaceuticals, a division of Bausch Health US, LLC. Salix Pharmaceuticals had no involvement in the creation of the content, including author selection, manuscript development or peer review. The views and opinions expressed in the articles are those of the authors. Conflicts of interest This author discloses the following: Elliot Tapper has served as a consultant to Norvartis, Axcella, and Allergan; has served on advisory boards for Mallinckrodt, Bausch Health, Kaleido, and Novo Nordisk; and has received unrestricted research grants from Gilead and Valeant. The remaining authors disclose no conflicts. Funding Elliot Tapper receives funding from the National Institutes of Health, United States through National Institute of Diabetes and Digestive and Kidney Diseases, United States (1K23DK117055, U01DK130113). Jeremy Louissaint is a recipient of the American Association for the Study of Liver Diseases Advanced Hepatology Award 2021. Sasha Deutsch-Link was supported in part by National Institutes of Health grant T32DK007634. Funding Information: Funding Elliot Tapper receives funding from the National Institutes of Health, United States through National Institute of Diabetes and Digestive and Kidney Diseases, United States (1K23DK117055, U01DK130113). Jeremy Louissaint is a recipient of the American Association for the Study of Liver Diseases Advanced Hepatology Award 2021. Sasha Deutsch-Link was supported in part by National Institutes of Health grant T32DK007634.
PY - 2022/8
Y1 - 2022/8
KW - Cognitive Dysfunction
KW - Encephalopathy
KW - Liver Disease
UR - http://www.scopus.com/inward/record.url?scp=85135549844&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85135549844&partnerID=8YFLogxK
U2 - 10.1016/j.cgh.2022.04.036
DO - 10.1016/j.cgh.2022.04.036
M3 - Review article
C2 - 35940729
AN - SCOPUS:85135549844
SN - 1542-3565
VL - 20
SP - S1-S8
JO - Clinical Gastroenterology and Hepatology
JF - Clinical Gastroenterology and Hepatology
IS - 8
ER -